DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Long GV, Stroyakovskiy D, Gogas H. et al.
Dabrafenib and Trametinib Versus Dabrafenib and Placebo for Val600 BRAF-mutant Melanoma: A Multicentre, Double-Blind, Phase 3 Randomised Controlled Trial.
Lancet 2015;
386: 444-451
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.